# FDA recall D-66373-001

> **Sandoz Incorporated** · Class III · drug recall initiated 2013-09-25.

## Product

Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01.

## Reason for recall

Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-66373-001
- **Recalling firm:** Sandoz Incorporated
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-09-25
- **Report date:** 2013-10-16
- **Termination date:** 2014-07-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Broomfield, CO, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-66373-001

## Citation

> AI Analytics. FDA recall D-66373-001. Retrieved 2026-07-08 from https://api.ai-analytics.org/recall/D-66373-001. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*